Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
NOD2 Signaling Circuitry during Allergen Sensitization Does Not Worsen Experimental Neutrophilic Asthma but Promotes a Th2/Th17 Profile in Asthma Patients but Not Healthy Subjects.
Bouté M, Ait Yahia S, Fan Y, Alvarez-Simon D, Vorng H, Balsamelli J, Nanou J, de Nadai P, Chenivesse C, Tsicopoulos A. Bouté M, et al. Among authors: chenivesse c. Int J Mol Sci. 2022 Oct 6;23(19):11894. doi: 10.3390/ijms231911894. Int J Mol Sci. 2022. PMID: 36233196 Free PMC article.
Dyspnoea: a multidimensional and multidisciplinary approach.
Laviolette L, Laveneziana P; ERS Research Seminar Faculty. Laviolette L, et al. Eur Respir J. 2014 Jun;43(6):1750-62. doi: 10.1183/09031936.00092613. Epub 2014 Feb 13. Eur Respir J. 2014. PMID: 24525437 Free article. Review.
Lung Volume Reduction Coil Treatment vs Usual Care in Patients With Severe Emphysema: The REVOLENS Randomized Clinical Trial.
Deslée G, Mal H, Dutau H, Bourdin A, Vergnon JM, Pison C, Kessler R, Jounieaux V, Thiberville L, Leroy S, Marceau A, Laroumagne S, Mallet JP, Dukic S, Barbe C, Bulsei J, Jolly D, Durand-Zaleski I, Marquette CH; REVOLENS Study Group. Deslée G, et al. JAMA. 2016 Jan 12;315(2):175-84. doi: 10.1001/jama.2015.17821. JAMA. 2016. PMID: 26757466 Free article. Clinical Trial.
Evaluation of efficacy and safety of rituximab in patients with progressive interstitial lung disease (ILD) with inflammatory component (EvER-ILD2): A multicentre double-blind placebo-controlled randomized trial.
Ferreira M, Bejan-Angoulvant T, Marchand-Adam S, Mousset E, Mureau E, Jouneau S, Nunes H, Montani D, Chenivesse C, Cadranel J, Bonniaud P, Crestani B, Cottin V, Caille A; OrphaLung.. Ferreira M, et al. Among authors: chenivesse c. Respir Med Res. 2024 Nov 28;87:101144. doi: 10.1016/j.resmer.2024.101144. Online ahead of print. Respir Med Res. 2024. PMID: 39693827
Involvement of CCL18 in allergic asthma.
de Nadaï P, Charbonnier AS, Chenivesse C, Sénéchal S, Fournier C, Gilet J, Vorng H, Chang Y, Gosset P, Wallaert B, Tonnel AB, Lassalle P, Tsicopoulos A. de Nadaï P, et al. Among authors: chenivesse c. J Immunol. 2006 May 15;176(10):6286-93. doi: 10.4049/jimmunol.176.10.6286. J Immunol. 2006. PMID: 16670340
126 results